Stay updated about the latest news on regulatory approvals and gain valuable insights into the intricate landscape of regulatory frameworks, guidelines, and processes that govern the development and commercialization of innovative therapies in the biotech sector!
News and Trends 28 Jul 2023
FDA grants breakthrough therapy designation to Duchenne muscular dystrophy treatment
The U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy Designation to NS Pharma Inc.’s NS-089/NCNP-02, an investigational candidate for patients with Duchenne muscular dystrophy amenable to exon 44…
